A Biotech Production Facility Contamination Case Study—Minute Mouse Virus

Jim Skrine

doi:10.5731/pdajpst.2011.00823

OtherConference Proceeding

A Biotech Production Facility Contamination Case Study—Minute Mouse Virus

Jim Skrine

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 599-611; DOI: https://doi.org/10.5731/pdajpst.2011.00823

Jim Skrine

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
References
Info & Metrics
PDF

Article Information

vol. 65 no. 6 599-611

DOI

https://doi.org/10.5731/pdajpst.2011.00823

PubMed

22294582

Published By

Parenteral Drug Association (PDA)

Print ISSN

1079-7440

Online ISSN

1948-2124

History

Published online January 4, 2012.

Author Information

Jim Skrine

Executive Director, North America, Operations Quality, Amgen

Jskrine{at}amgen.com

View Full Text

Cited By...

15 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Viral clearance for biopharmaceutical downstream processes

Abhinav A Shukla, Hazel Aranha

Pharmaceutical Bioprocessing 2015 3 2
A novel approach to achieving modular retrovirus clearance for a parvovirus filter

Juliana Stuckey, Daniel Strauss, Adith Venkiteshwaran, Jinxin Gao, Wen Luo, Michelle Quertinmont, Sean O'Donnell, Dayue Chen

Biotechnology Progress 2014 30 1
Growth media filtration using nanocellulose-based virus removal filter for upstream biopharmaceutical processing

Levon Manukyan, Pengfei Li, Simon Gustafsson, Albert Mihranyan

Journal of Membrane Science 2019 572
New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins

Brian Kelley, Robert Kiss, Michael Laird

2018 165
Choice of parvovirus model for validation studies influences the interpretation of the effectiveness of a virus filtration step

Thomas Nowak, Birgit Popp, Nathan J. Roth

Biologicals 2019 60
Genetic engineering of CHO cells for viral resistance to minute virus of mice

Joaquina X. Mascarenhas, Nikolay Korokhov, Lisa Burger, Ademola Kassim, Jason Tuter, Daniel Miller, Trissa Borgschulte, Henry J. George, Audrey Chang, David J. Pintel, David Onions, Kevin J. Kayser

Biotechnology and Bioengineering 2017 114 3
ICH Quality Guidelines

Daniel Galbraith

2017
ICH Quality Guidelines

Mark Plavsic

2017
Ultraviolet irradiation of trypsin, lysozyme and β-galactosidase: how does UVC affect these enzymes when used as a secondary barrier against adventitious agents?

Michelle A. Gabriel, Emma V. Dare, Sarah M. Meunier, J. Larry Campbell, Michael R. Sasges, Marc G. Aucoin

Vaccine 2019 37 43
Detection of Minute virus of mice strains in different cell lines: Implications for adventitious agent testing

Maria R. Farcet, Jens Modrof, Gerhard Antoine, Cecilie Klausen, Astrid Kerschbaum, Martina Kopp, Houman Dehghani, Thomas R. Kreil

Biotechnology and Bioengineering 2024 121 1
Developing a Model for Virus Contamination in Perfusion Bioreactors to Establish Rational Control Strategies for Integrated Continuous Bioprocessing

Takao ITO, Takashi Nihei, Koichi Yamamoto, Naoto Watanabe, Yoshiyuki Tokieda, Yumiko Masuda, Masaki Okada

Biotechnology and Bioengineering 2025
Mammalian Cell Cultures for Biologics Manufacturing

Dayue Chen

2013 139
Revisiting mouse minute virus inactivation by high temperature short time treatment

Joleen Su, Jonathan Rice, Jacob Hoffman, Shelley Alvarado, Mark Bailey, Martina Kopp, Marie Murphy, Robert Kiss, Paul W. Barone, Michael E. Wiebe, Stacy L. Springs, Houman Dehghani, Dayue Chen

Biotechnology and Bioengineering 2021 118 8
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

John Geigert

2019
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals and Other Biologics

John Geigert

2013

PreviousNext

In This Issue

PDA Journal of Pharmaceutical Science and Technology

Vol. 65, Issue 6

November/December 2011

Table of Contents
Index by Author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following A Biotech Production Facility Contamination Case Study—Minute Mouse Virus

Message Subject (Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology

Message Body (Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 1 + 2 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

A Biotech Production Facility Contamination Case Study—Minute Mouse Virus

Jim Skrine

PDA Journal of Pharmaceutical Science and Technology Nov 2011, 65 (6) 599-611; DOI: 10.5731/pdajpst.2011.00823

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

A Biotech Production Facility Contamination Case Study—Minute Mouse Virus

Jim Skrine

PDA Journal of Pharmaceutical Science and Technology Nov 2011, 65 (6) 599-611; DOI: 10.5731/pdajpst.2011.00823

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
- Abstract
Figures & Data
References
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Detection of Adventitious Agents Using Next-Generation Sequencing
Meeting Report: 2013 PDA Virus & TSE Safety Forum

Google Scholar

Conference Proceeding

Proceedings of the 2017 Viral Clearance Symposium, Session 4: Submission Strategies
Proceedings of the 2017 Viral Clearance Symposium Session 5: Facility Risk Mitigation
Proceedings of the 2017 Viral Clearance Symposium: Conclusion

Show more Conference Proceeding

Plenary Session 3 and 4: Review and Viral Contamination and Case Studies

Mouse Minute Virus (MMV) Contamination—A Case Study: Detection, Root Cause Determination, and Corrective Actions
Case Study of Apparent Virus Contamination in Biopharmaceutical Product at Centocor
Identification and Remediation of a Cell Culture Virus Contamination

Show more Plenary Session 3 and 4: Review and Viral Contamination and Case Studies

Slide Presentation

Mouse Minute Virus (MMV) Contamination—A Case Study: Detection, Root Cause Determination, and Corrective Actions
Case Study of Apparent Virus Contamination in Biopharmaceutical Product at Centocor
Identification and Remediation of a Cell Culture Virus Contamination

Show more Slide Presentation

Main menu

User menu

Search

A Biotech Production Facility Contamination Case Study—Minute Mouse Virus

Article Information

Author Information

Cited By...

In This Issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Conference Proceeding

Plenary Session 3 and 4: Review and Viral Contamination and Case Studies

Slide Presentation

Similar Articles

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.